BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15382305)

  • 1. Imaging of pleural and chest wall tumors.
    Weyant MJ; Flores RM
    Thorac Surg Clin; 2004 Feb; 14(1):15-23. PubMed ID: 15382305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic and functional imaging of malignant pleural mesothelioma.
    Yamamuro M; Gerbaudo VH; Gill RR; Jacobson FL; Sugarbaker DJ; Hatabu H
    Eur J Radiol; 2007 Dec; 64(3):356-66. PubMed ID: 17954021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the best way to diagnose and stage malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of the mediastinum: applications for thoracic surgery.
    Shaham D; Skilakaki MG; Goitein O
    Thorac Surg Clin; 2004 Feb; 14(1):25-42. PubMed ID: 15382306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current state of imaging for lung cancer staging.
    Kent MS; Port JL; Altorki NK
    Thorac Surg Clin; 2004 Feb; 14(1):1-13. PubMed ID: 15382304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
    Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of pleural masses: which to choose?
    Bruns AS; Mastronarde JG
    Respir Med; 2008 Mar; 102(3):328-31. PubMed ID: 18086520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
    Wang ZJ; Reddy GP; Gotway MB; Higgins CB; Jablons DM; Ramaswamy M; Hawkins RA; Webb WR
    Radiographics; 2004; 24(1):105-19. PubMed ID: 14730040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging for esophageal tumors.
    Korst RJ; Altorki NK
    Thorac Surg Clin; 2004 Feb; 14(1):61-9. PubMed ID: 15382309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anterior mediastinal tumors: diagnostic accuracy of CT and MRI.
    Tomiyama N; Honda O; Tsubamoto M; Inoue A; Sumikawa H; Kuriyama K; Kusumoto M; Johkoh T; Nakamura H
    Eur J Radiol; 2009 Feb; 69(2):280-8. PubMed ID: 18023547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
    Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
    Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of mesothelioma.
    Gill RR
    Recent Results Cancer Res; 2011; 189():27-43. PubMed ID: 21479894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging before and after multimodal treatment for malignant pleural mesothelioma.
    Fiore D; Baggio V; Sotti G; Muzzio PC
    Radiol Med; 2006 Apr; 111(3):355-64. PubMed ID: 16683083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of chest wall invasion by lung cancer: useful criteria for exclusion of the possibility of chest wall invasion with MR imaging.
    Shiotani S; Sugimura K; Sugihara M; Kawamitsu H; Yamauchi M; Yoshida M; Kushima T; Kinoshita T; Endoh H; Nakayama H; Kajitani M; Wada M
    Radiat Med; 2000; 18(5):283-90. PubMed ID: 11128398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases].
    Falaschi F; Battolla L; Zampa V; Cioni R; Cambi L; Antonelli A; Bartolozzi C
    Radiol Med; 1996 Dec; 92(6):713-8. PubMed ID: 9122459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.